Predictors of Fecal Elastase Testing Completion in Outpatient and Inpatient Settings: A Single Center Retrospective Analysis
OBJECTIVES: To characterize completion of fecal elastase-1 (FE-1) testing, identify clinical contexts associated with abnormal results, evaluate downstream diagnostic and treatment events, and determine the clinical significance of non-completion. METHODS: We conducted a retrospective cohort study of adults with FE-1 orders from 2017 through 2022 in a large integrated health system. Orders placed within 30 days were consolidated into diagnostic episodes. Completion required a linked specimen with a reported result. We evaluated pre-order clinical contexts and one-year outcomes and performed a weighted manual chart review of 200 unique patients with non-completed episodes sampled from four downstream pathway strata. RESULTS: Among 23,422 diagnostic episodes, 11,834 (50.5%) were completed. FE-1 ≤200 µg/g occurred in 20.4% of interpretable results and varied by clinical context: 13.7% with irritable bowel syndrome, 21.2% with chronic diarrhea, 38.3% with chronic pancreatitis, 60.1% with pancreatic cancer, and 79.5% after pancreatic surgery. Initial completion was associated with higher odds of new exocrine pancreatic insufficiency diagnosis (adjusted odds ratio, 2.27; 95% confidence interval, 1.91-2.70) and pancreatic enzyme replacement therapy initiation (adjusted odds ratio, 2.20; 95% confidence interval, 1.89-2.55), whereas non-completion was associated with more repeat FE-1 testing. Among eligible unique non-completers, weighted chart review classified 66.9% as probable missed diagnostic follow-through based on available documentation; failure to submit or return the specimen (60.1%) and specimen-processing problems (20.4%) predominated. CONCLUSIONS: FE-1 completion was modestly associated with measured pre-order factors, while abnormal results varied substantially by clinical context. Specimen return, processing, and closed-loop follow-up represent potential targets for improving evaluation of exocrine pancreatic insufficiency.
Authors
- Kunzah A. Syed (ORCID: https://orcid.org/0000-0003-4357-7910)
- Ridhima Kaul (ORCID: https://orcid.org/0000-0003-3487-2512)
- Arjun Chatterjee (ORCID: https://orcid.org/0000-0003-4707-988X)
- Mitchell L. Ramsey (ORCID: https://orcid.org/0000-0002-6430-1924)
- Abdullah Allaoa
- John McMichael
- Tyler Stevens
- Stephen Firkins
- Hassan Siddiki
- Syed Mohiuddin
- Renan Prado
- Georgios Papachristou
- Pavan Krishna Kottachalla
- FNU Vikash
- Ishani Patel
- Prabhleen Chahal
Institutions
- Cleveland Clinic (US)
- The University of Texas System (US)
- The University of Texas at San Antonio Health Science Center (US)
- The Ohio State University Wexner Medical Center (US)
Publication Details
- Journal
- Pancreas
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1097/mpa.0000000000002738
- Primary Topic
- Pancreatitis Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00